Works by Tan, Antoinette R.

Results: 29

Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors.

Published in:

Oncologist, 2010, v. 15, n. 12, p. 1253, doi. 10.1634/theoncologist.2010-0095

By:

TAN, ANTOINETTE R.;
DOWLATI, AFSHIN;
JONES, SUZANNE F.;
INFANTE, JEFFREY R.;
NISHIOKA, JENNIFER;
FANG, LEI;
HODGE, JEFFREY P.;
GAINER, SHELBY D.;
ARUMUGHAM, THANGAM;
SUTTLE, A. BENJAMIN;
DAR, MOHAMMED M.;
LAGER, JOANNE J.;
BURRIS III, HOWARD A.

Publication type:

Article

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1235902

By:

Sammons, Sarah;
Elliott, Andrew;
Barroso-Sousa, Romualdo;
Chumsri, Saranya;
Tan, Antoinette R.;
Sledge Jr., George W.;
Tolaney, Sara M.;
Torres, Evanthia T. Roussos

Publication type:

Article

A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.

Published in:

Cancer (0008543X), 2012, v. 118, n. 17, p. 4262, doi. 10.1002/cncr.27428

By:

Rocha-Lima, Caio M.;
Bayraktar, Soley;
MacIntyre, Jessica;
Raez, Luis;
Flores, Aurea M.;
Ferrell, Annapoorna;
Rubin, Eric H.;
Poplin, Elizabeth A.;
Tan, Antoinette R.;
Lucarelli, Antonio;
Zojwalla, Naseem

Publication type:

Article

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 5, p. 721, doi. 10.1007/s00280-022-04430-6

By:

Manzo, Julia;
Puhalla, Shannon;
Pahuja, Shalu;
Ding, Fei;
Lin, Yan;
Appleman, Leonard;
Tawbi, Hussein;
Stoller, Ronald;
Lee, James J.;
Diergaarde, Brenda;
Kiesel, Brian F.;
Yu, Jing;
Tan, Antoinette R.;
Belani, Chandra P.;
Chew, Helen;
Garcia, Agustin A.;
Morgan, Robert J.;
Wahner Hendrickson, Andrea E.;
Visscher, Daniel W.;
Hurley, Rachel M.

Publication type:

Article

A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 49, doi. 10.1007/s00280-021-04350-x

By:

Tan, Antoinette R.;
Chan, Nancy;
Kiesel, Brian F.;
Stein, Mark N.;
Moss, Rebecca A.;
Malhotra, Jyoti;
Aisner, Joseph;
Shah, Mansi;
Gounder, Murugesan;
Lin, Hongxia;
Kane, Michael P.;
Lin, Yong;
Ji, Jiuping;
Chen, Alice;
Beumer, Jan H.;
Mehnert, Janice M.

Publication type:

Article

Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

Published in:

2020

By:

Tolcher, Anthony W.;
Kurzrock, Razelle;
Valero, Vincente;
Gonzalez, Rene;
Heist, Rebecca S.;
Tan, Antoinette R.;
Means-Powell, Julie;
Werner, Theresa L.;
Becerra, Carlos;
Wang, Chenxi;
Leonowens, Cathrine;
Kalyana-Sundaram, Shanker;
Kleha, Joseph F.;
Gauvin, Jennifer;
D'Amelio, Anthony M.;
Ellis, Catherine;
Ibrahim, Nageatte;
Yan, Li;
D'Amelio, Anthony M Jr

Publication type:

journal article

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.

Published in:

2019

By:

Mehnert, Janice M.;
Kaveney, Amanda D.;
Malhotra, Jyoti;
Spencer, Kristen;
Portal, Daniella;
Goodin, Susan;
Tan, Antoinette R.;
Aisner, Joseph;
Moss, Rebecca A.;
Lin, Hongxia;
Bertino, Joseph R.;
Gibbon, Darlene;
Doyle, Laurence A.;
White, Eileen P.;
Stein, Mark N.

Publication type:

journal article

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.

Published in:

2016

By:

Chow, Laura;
Smith, David;
Tan, Antoinette;
Denlinger, Crystal;
Wang, Ding;
Shepard, Dale;
Chaudhary, Archana;
Lin, Yong;
Gao, Ling;
Chow, Laura Q M;
Smith, David C;
Tan, Antoinette R;
Denlinger, Crystal S;
Shepard, Dale R

Publication type:

journal article

Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function.

Published in:

2015

By:

Tan, Antoinette;
Sarantopoulos, John;
Lee, Lucy;
Reyderman, Larisa;
He, Yi;
Olivo, Martin;
Goel, Sanjay;
Tan, Antoinette R

Publication type:

journal article

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.

Published in:

2013

By:

Jankowitz, Rachel C;
Abraham, Jame;
Tan, Antoinette R;
Limentani, Steven A;
Tierno, Marni B;
Adamson, Laura M;
Buyse, Marc;
Wolmark, Norman;
Jacobs, Samuel A

Publication type:

journal article

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1205, doi. 10.1007/s00280-013-2262-2

By:

Jankowitz, Rachel C.;
Abraham, Jame;
Tan, Antoinette R.;
Limentani, Steven A.;
Tierno, Marni B.;
Adamson, Laura M.;
Buyse, Marc;
Wolmark, Norman;
Jacobs, Samuel A.

Publication type:

Article

Trilaciclib: A First-in-class Therapy to Reduce Chemotherapy-induced Myelosuppression.

Published in:

touchREVIEWS in Oncology & Haematology, 2022, v. 18, n. 2, p. 152, doi. 10.17925/OHR.2022.18.2.152

By:

Young, Joanna A.;
Tan, Antoinette R.

Publication type:

Article

Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study.

Published in:

Cancer Medicine, 2018, v. 7, n. 6, p. 2360, doi. 10.1002/cam4.1488

By:

Werner, Theresa L.;
Sachdev, Jasgit;
Swisher, Elizabeth M.;
Gutierrez, Martin;
Kittaneh, Muaiad;
Stein, Mark N.;
Xiong, Hao;
Dunbar, Martin;
Sullivan, Danielle;
Komarnitsky, Philip;
Mckee, Mark;
Tan, Antoinette R.

Publication type:

Article

ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy?

Published in:

2022

By:

Pestana, Christine V.;
Livasy, Chad A;
Donahue, Erin E;
Neelands, Brittany;
Tan, Antoinette R.;
Sarantou, Terry;
Hadzikadic-Gusic, Lejla;
White Jr., Richard L.

Publication type:

Abstract

Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7716, doi. 10.1245/s10434-022-12038-6

By:

Pestana, Christine V.;
Livasy, Chad A.;
Donahue, Erin E.;
Neelands, Brittany;
Tan, Antoinette R.;
Sarantou, Terry;
Hadzikadic-Gusic, Lejla;
White Jr, Richard L.

Publication type:

Article

Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer.

Published in:

Expert Opinion on Biological Therapy, 2022, v. 22, n. 3, p. 385, doi. 10.1080/14712598.2021.1981284

By:

Matusz-Fisher, Ashley;
Tan, Antoinette R.

Publication type:

Article

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer.

Published in:

Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 537, doi. 10.1007/s10555-021-09972-4

By:

Heeke, Arielle L.;
Tan, Antoinette R.

Publication type:

Article

Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer.

Published in:

Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 307, doi. 10.1007/s10549-023-07009-8

By:

Tan, Antoinette R.;
O'Shaughnessy, Joyce;
Cao, Subing;
Ahn, Sarah;
Yi, John S.

Publication type:

Article

Molecular characterization of ESR1 variants in breast cancer.

Published in:

Breast Cancer Research & Treatment, 2022, v. 196, n. 2, p. 279, doi. 10.1007/s10549-022-06740-y

By:

Heeke, Arielle L.;
Elliott, Andrew;
Feldman, Rebecca;
O'Connor, Hazel F.;
Pohlmann, Paula R.;
Lynce, Filipa;
Swain, Sandra M.;
Nunes, Maria R.;
Magee, Daniel;
Oberley, Matthew J.;
Swenson, Jeffrey;
Vidal, Gregory;
Isaacs, Claudine;
Schwartzberg, Lee;
Korn, W. Michael;
Tan, Antoinette R.

Publication type:

Article

The Genomic Landscape of Breast Cancer in Young and Older Women.

Published in:

Clinical Breast Cancer, 2024, v. 24, n. 7, p. 630, doi. 10.1016/j.clbc.2024.07.008

By:

Heeke, Arielle L.;
Wei Sha;
Feldman, Rebecca;
Fisher, Julie;
Hadzikadic-Gusic, Lejla;
Symanowski, James T.;
White Jr, Richard L.;
Tan, Antoinette R.

Publication type:

Article

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer.

Published in:

Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01475

By:

Khoury, Katia;
Tan, Antoinette R.;
Elliott, Andrew;
Xiu, Joanne;
Gatalica, Zoran;
Heeke, Arielle L.;
Isaacs, Claudine;
Pohlmann, Paula R.;
Schwartzberg, Lee S.;
Simon, Michael;
Korn, W. Michael;
Swain, Sandra M.;
Lynce, Filipa

Publication type:

Article

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

Published in:

2019

By:

El‐Deiry, Wafik S.;
Goldberg, Richard M.;
Lenz, Heinz‐Josef;
Shields, Anthony F.;
Gibney, Geoffrey T.;
Tan, Antoinette R.;
Brown, Jubilee;
Eisenberg, Burton;
Heath, Elisabeth I.;
Phuphanich, Surasak;
Kim, Edward;
Brenner, Andrew J.;
Marshall, John L.;
El-Deiry, Wafik S;
Lenz, Heinz-Josef

Publication type:

journal article

Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.

Published in:

PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090353

By:

Morris, John C.;
Tan, Antoinette R.;
Olencki, Thomas E.;
Shapiro, Geoffrey I.;
Dezube, Bruce J.;
Reiss, Michael;
Hsu, Frank J.;
Berzofsky, Jay A.;
Lawrence, Donald P.

Publication type:

Article

The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer.

Published in:

Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 5, p. 305

By:

Steiner, Meghan;
Tan, Antoinette R.

Publication type:

Article

Development of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of BRCA-Mutated Breast Cancer.

Published in:

Clinical Advances in Hematology & Oncology, 2018, p. 491

By:

Sulai, Nanna H.;
Tan, Antoinette R.

Publication type:

Article

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

Published in:

Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5

By:

Dent, Rebecca;
Oliveira, Mafalda;
Isakoff, Steven J.;
Im, Seock-Ah;
Espié, Marc;
Blau, Sibel;
Tan, Antoinette R.;
Saura, Cristina;
Wongchenko, Matthew J.;
Xu, Na;
Bradley, Denise;
Reilly, Sarah-Jayne;
Mani, Aruna;
Kim, Sung-Bae;
on behalf of the LOTUS investigators;
Lee, K. S.;
Sohn, J. H.;
Kim, J. H.;
Seo, J. H.;
Kim, J. S.

Publication type:

Article

Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.

Published in:

Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 265, doi. 10.1007/s10549-020-05849-2

By:

Heeke, Arielle L.;
Xiu, Joanne;
Elliott, Andrew;
Korn, W. Michael;
Lynce, Filipa;
Pohlmann, Paula R.;
Isaacs, Claudine;
Swain, Sandra M.;
Vidal, Gregory;
Schwartzberg, Lee S.;
Tan, Antoinette R.

Publication type:

Article

Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer.

Published in:

Breast Cancer: Targets & Therapy, 2024, v. 16, p. 517, doi. 10.2147/BCTT.S271441

By:

O'Keefe, Kaitlyn;
Desai, Neelam V;
Tan, Antoinette R

Publication type:

Article

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data.

Published in:

Breast Cancer: Targets & Therapy, 2021, v. 13, p. 393, doi. 10.2147/BCTT.S176514

By:

Jagosky, Megan;
Tan, Antoinette R

Publication type:

Article